Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
38.99
+1.05 (2.77%)
At close: Apr 15, 2026
Market Cap4.22B +13.9%
Revenue (ttm)435.52M -0.5%
Net Income52.06M +3.8%
EPS0.48 +4.2%
Shares Out108.29M
PE Ratio80.62
Forward PEn/a
Dividend0.20 (0.53%)
Ex-Dividend DateMay 20, 2025
Volume4,638,700
Average Volume5,214,947
Open37.92
Previous Close37.94
Day's Range37.72 - 39.50
52-Week Range25.87 - 53.99
Beta-0.13
RSI49.42
Earnings DateApr 16, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofe... [Read more]

Sector Healthcare
Founded 2004
Employees 696
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2024, SHE:301281's revenue was 463.72 million, an increase of 3.60% compared to the previous year's 447.58 million. Earnings were 60.27 million, a decrease of -21.76%.

Financial Statements